Vanguard Fiduciary Trust’s Bio-Techne TECH Stock Holding History

Vanguard Fiduciary Trust’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$62.1M	Sell	879,237 -1,315	-0.1%	-$71K	0.01%	752
2026 Q1	$46M	Buy	+880,552	New	+$52.9M	0.01%	829

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Fiduciary Trust's TECH Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its Bio-Techne (TECH) stake by 0.15% in Q2 2026, selling an estimated $71K and leaving 879,237 shares worth $62.1M. The position accounts for 0.01% of the portfolio, ranked #752.

Vanguard Fiduciary Trust first reported a position in TECH in Q1 2026 and has held it in 2 quarters since. 590 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Vanguard Fiduciary Trust held 879,237 shares of Bio-Techne worth $62.1M as of Q2 2026.
Vanguard Fiduciary Trust sold 1,315 Bio-Techne shares in Q2 2026, an estimated $71K.
Bio-Techne made up 0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #752 holding.
Vanguard Fiduciary Trust first reported a position in Bio-Techne in Q1 2026 and has held it in 2 quarters since.
590 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.